Mass Spectrometry Workflow for ADC Peptide Site Occupancy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing conjugated peptides in antibody-drug conjugates (ADCs) face challenges such as low sensitivity, insufficient selectivity, and long analysis times, particularly in determining site occupancy ratios, which are crucial for ensuring product quality and efficacy.
Innovation Solution
A streamlined workflow involving ionization of ADC samples to form radical ion fragments, followed by detection of mass-to-charge ratios using mass spectrometry, allows for the identification and quantification of conjugated and unconjugated peptides, enabling precise determination of site occupancy ratios.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If UV methods are used for quantification of conjugated peptides, then the analysis can be performed with simple equipment, but the sensitivity is low and selectivity is insufficient
Solution Approach 1:
The patent replaces UV detection (optical method) with mass spectrometry detection. The mass spectrometer measures mass-to-charge ratios of ionized peptides, providing superior selectivity and sensitivity for identifying conjugated peptides and determining site occupancy ratios in ADC compounds.
Solution Approach 2:
The patent changes the detection parameter from UV absorbance to mass-to-charge ratio. By ionizing peptides and measuring their mass-to-charge ratios, the method achieves higher selectivity in distinguishing conjugated peptides from unconjugated peptides and degradation products.
2Measurement precision
If UV methods are used for quantification of conjugated peptides, then the equipment setup is simple, but the analysis time is relatively long
Solution Approach 1:
The patent replaces UV detection with mass spectrometry detection. The mass spectrometer provides higher sensitivity for detecting conjugated peptides at lower concentrations and reduces analysis time through faster data acquisition and processing capabilities.
Solution Approach 2:
The patent uses proteolytic enzymes to digest the ADC compound into smaller peptide fragments. This segmentation allows the mass spectrometer to detect and quantify specific conjugated peptides more sensitively and rapidly, improving both sensitivity and analysis time.
3Measurement precision
If mass spectrometry is used for quantification, then selectivity and sensitivity are improved, but a complete workflow for efficient identification and quantification was previously lacking
Solution Approach 1:
The patent establishes a universal, multi-step workflow that can be applied to any ADC compound for identifying and quantifying conjugated peptides. The workflow includes sample preparation, proteolytic digestion, liquid chromatography separation, and mass spectrometry detection, providing a complete and transferable methodology across different ADC platforms.
Solution Approach 2:
The patent performs preliminary proteolytic digestion of the ADC compound into peptides before mass spectrometry analysis. This preliminary action simplifies the subsequent detection step by breaking down the large ADC molecule into smaller, more detectable peptide fragments, enabling efficient identification and quantification.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides higher selectivity and sensitivity, significantly reducing analysis time and improving the accuracy of site occupancy determination, thereby enhancing the characterization and quality control of ADCs.
Implementation Method 1
One step involves ionizing a sample comprising an antibody-drug conjugate compound and a peptide. Ionization serves to form radical ion fragments of the antibody-drug conjugate compound and of the peptide.
Data Source
AI summary
The present disclosure relates to a streamlined, complete workflow for the qualitative and the quantitative analysis of conjugated peptides from antibody-drug conjugate (ADC) compounds.